Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Shareholders of revenue cycle management services company Accretive Health
So what: In late March, Accretive Health agreed to no longer collect debt on behalf of Fairview Health Services in response to this same lawsuit. Today's news widens the scope of that investigation beyond just Fairview, and the allegations made by the attorney general contend that Accretive's employees didn't properly disclose their roles to patients and that they attempted, in some cases, to collect from patients prior to them even receiving care. Further, it appears that Fairview Health's tax-exempt status may be in jeopardy because of Accretive's aggressive debt-collecting tactics.
Now what: Last month when Accretive announced the loss of the Fairview account, it shaved about 6% of its revenue off its full-year forecast. With the scope of this investigation expanding, it's quite possible the impact to Accretive's bottom line may expand as well. At some point Accretive will be worth a look, but even after today's drop, 14 times forward earnings is still too much to pay with so many questions still on the table.
Craving more input? Start by adding Accretive Health to your free and personalized watchlist so you can keep up on the latest news with the company.